New search | Conferencedetail
Print view
 
 

Scleroderma Drug Development Summit Boston 2018

evvnt Platform / evvnt
Conference themes
The Scleroderma Drug Development Summit is industry's first networking and discussion forum dedicated to overcoming translational challenges in achieving disease modifying scleroderma therapeutics.
Professional congress organizer (PCO)
Aarti Diwan
Notes
Speakers: Marek Honczarenko (AbbVie), Jeffrey Siegel (Genentech), Gerald Horan (Celgene), Mark Tepper (Corbus Pharmaceuticals), Nicolas Wisniacki (GlaxoSmithKline)
 

Enquiries and Registration:

https://go.evvnt.com/214983-1?pid=4832
Ms. Aarti Diwan
 
Categories
Public Health
Languages
English
Congress fees
GOLD: USD 3997.0, SILVER: USD 3398.0, BRONZE: USD 2799.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnomedizin e. V.European Public Health Association (EUPHA)OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Anästhesie in Entwicklungsländern e. V.Ärzte der WeltHilfswerk AustrianewTreeÖsterreichisches Rotes Kreuz

Facebook

Give us your professional opinion

Start survey

Start survey